Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Seres Therapeutics (MCRB) over the last 11 years, with Q3 2025 value amounting to $3.1 million.

  • Seres Therapeutics' Prepaid Assets fell 4901.7% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 4901.7%. This contributed to the annual value of $5.8 million for FY2024, which is 2777.98% down from last year.
  • Latest data reveals that Seres Therapeutics reported Prepaid Assets of $3.1 million as of Q3 2025, which was down 4901.7% from $2.4 million recorded in Q2 2025.
  • Seres Therapeutics' 5-year Prepaid Assets high stood at $15.2 million for Q1 2022, and its period low was $2.4 million during Q2 2025.
  • Its 5-year average for Prepaid Assets is $8.6 million, with a median of $8.8 million in 2021.
  • In the last 5 years, Seres Therapeutics' Prepaid Assets surged by 13195.92% in 2022 and then crashed by 6233.1% in 2025.
  • Over the past 5 years, Seres Therapeutics' Prepaid Assets (Quarter) stood at $12.9 million in 2021, then rose by 3.88% to $13.4 million in 2022, then plummeted by 40.04% to $8.0 million in 2023, then decreased by 27.78% to $5.8 million in 2024, then crashed by 46.46% to $3.1 million in 2025.
  • Its last three reported values are $3.1 million in Q3 2025, $2.4 million for Q2 2025, and $4.5 million during Q1 2025.